These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 28671148)
1. Randomized controlled trials: Ethical and scientific issues in the choice of placebo or active control. Ovosi JO; Ibrahim MS; Bello-Ovosi BO Ann Afr Med; 2017; 16(3):97-100. PubMed ID: 28671148 [TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled trials in psychiatric research: an ethical perspective. Miller FG Biol Psychiatry; 2000 Apr; 47(8):707-16. PubMed ID: 10773177 [TBL] [Abstract][Full Text] [Related]
3. Indian study sparks debate on the use of placebo in psychiatry trials. Mudur G BMJ; 2006 Mar; 332(7541):566. PubMed ID: 16528065 [No Abstract] [Full Text] [Related]
4. Rebuttal to Dr Streiner: can the "evil" in the "lesser of 2 evils" be justified in placebo-controlled trials? Glass KC Can J Psychiatry; 2008 Jul; 53(7):433, discussion 434. PubMed ID: 18674399 [No Abstract] [Full Text] [Related]
5. Placebo control groups in randomized treatment trials: a statistician's perspective. Lavori PW Biol Psychiatry; 2000 Apr; 47(8):717-23. PubMed ID: 10773178 [TBL] [Abstract][Full Text] [Related]
6. Are antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial. Ashcroft R; Fraser B; Kerr M; Ahmed Z J Med Ethics; 2001 Oct; 27(5):338-43. PubMed ID: 11579192 [TBL] [Abstract][Full Text] [Related]
7. Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis. Block JJ Am J Psychiatry; 2006 Oct; 163(10):1838; author reply 1838. PubMed ID: 17012701 [No Abstract] [Full Text] [Related]
8. The use of placebos in clinical trials for acute schizophrenia. Addington D Can J Psychiatry; 1995 May; 40(4):171-6. PubMed ID: 7621385 [TBL] [Abstract][Full Text] [Related]
9. On the ethical acceptability of placebo application in neuropsychiatric research. De Deyn PP Acta Neurol Belg; 1995; 95(1):8-17. PubMed ID: 7725899 [No Abstract] [Full Text] [Related]
10. Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified? Emsley R; Fleischhacker WW Schizophr Res; 2013 Nov; 150(2-3):427-33. PubMed ID: 24094881 [TBL] [Abstract][Full Text] [Related]
11. The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective. Laughren TP Eur Psychiatry; 2001 Nov; 16(7):418-23. PubMed ID: 11728855 [TBL] [Abstract][Full Text] [Related]
12. The use of placebo control groups in the assessment of psychiatric drugs: an historical context. Leber P Biol Psychiatry; 2000 Apr; 47(8):699-706. PubMed ID: 10773176 [TBL] [Abstract][Full Text] [Related]
13. Ethics of placebo-controlled trial in severe mania. Patel V Indian J Med Ethics; 2006; 3(1):11-2. PubMed ID: 16832922 [No Abstract] [Full Text] [Related]
14. Using empirical data to inform the ethical evaluation of placebo controlled trials. Sugarman J Sci Eng Ethics; 2004 Jan; 10(1):29-35. PubMed ID: 14986768 [TBL] [Abstract][Full Text] [Related]
15. Ethical obligations and the use of placebo controls. Glass KC Can J Psychiatry; 2008 Jul; 53(7):428-9. PubMed ID: 18674397 [No Abstract] [Full Text] [Related]
16. What makes placebo-controlled trials unethical? Miller FG; Brody H Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059 [TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled trials in psychiatry on trial. Tharyan P Indian J Med Ethics; 2006; 3(1):13-6. PubMed ID: 16832923 [No Abstract] [Full Text] [Related]
18. Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary? Weijer C Schizophr Res; 1999 Feb; 35(3):211-8; discussion 227-36. PubMed ID: 10093865 [TBL] [Abstract][Full Text] [Related]
20. The Ethics of Placebo Effects in Clinical Practice and Research. Annoni M Int Rev Neurobiol; 2018; 139():463-484. PubMed ID: 30146058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]